<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For Quarter Ended September 30, 2000
Commission File Number 0-11353
CIRCUIT RESEARCH LABS, INC.
(Exact name of registrant as specified in its charter)
Arizona 86-0344671
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2522 West Geneva Drive, Tempe, Arizona 85282
(Address of Principal executive office) (Zip Code)
Registrant's telephone number,
including area code
(602) 438-0888
172743 20 51
(CUSIP Number)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES NO X
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the close of the period covered by this report.
<TABLE>
<CAPTION>
Outstanding at
Class September 30, 2000
----- ------------------
<S> <C>
Common stock, $.10 par value 2,119,522
</TABLE>
<PAGE> 2
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
INDEX
<TABLE>
<CAPTION>
Page
number
------
<S> <C>
Part I. FINANCIAL INFORMATION:
Item 1. Financial Statements (Unaudited)
Consolidated Condensed Balance Sheets
September 30, 2000 and December 31, 1999 2
Consolidated Condensed Statements of
Operations - Three and nine months ended
September 30, 2000 and 1999 4
Consolidated Condensed Statements of Cash
Flows - Nine months ended September 30, 2000
and 1999 5
Consolidated Statements of Shareholder's
Equity - Nine months ended September 30, 2000 7
Notes to Consolidated Condensed Financial
Statements 8
Item 2. Management's Discussion and Analysis
of Financial Condition and Results
of Operations 12
Part II. OTHER INFORMATION:
Item 2. Changes in use of securities and use of proceeds 16
Item 5. Other Information 16
Item 6. Exhibits and Reports on Form 8-K 16
Signatures 17
</TABLE>
1
<PAGE> 3
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(UNAUDITED)
<TABLE>
<CAPTION>
September 30, December 31,
2000 1999
------------ ------------
<S> <C> <C>
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 222,073 $ 62,597
Securities available-for-sale 383,905
Accounts receivable, less allowance for
doubtful accounts of $5,000 at September 30, 2000
and $9,715 at December 31, 1999 1,325,614 47,662
Inventories:
Raw materials and supplies 1,976,112 137,247
Work in process 579,214 118,233
Finished goods 1,259,579 305,725
----------- ----------
Total inventories, net of obsolescence reserve of $380,000
at September 30, 2000 and $380,000 at December 31, 1999 3,814,905 561,205
Prepaid expenses and other 418,192 40,219
----------- ----------
Total current assets 5,780,784 1,095,588
----------- ----------
PROPERTY, PLANT AND EQUIPMENT:
Land 130,869 130,869
Building and improvements 874,696 503,000
Furniture and fixtures 924,198
Machinery and equipment 1,141,551 518,272
----------- ----------
Total 3,071,314 1,437,308
Less accumulated depreciation 1,154,196 996,420
----------- ----------
Property, plant and equipment - net 1,917,118 440,888
GOODWILL - (Net of amortization of $282,187) 6,447,464
OTHER ASSETS 39,000 298,215
----------- ----------
TOTAL $14,184,366 $1,834,691
=========== ==========
</TABLE>
(continued)
2
<PAGE> 4
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(UNAUDITED)
<TABLE>
<CAPTION>
September 30, December 31,
2000 1999
------------- ------------
<S> <C> <C>
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $ 1,725,416 $ 70,732
Accrued salaries and benefits 273,570 34,684
Accrued professional fees 11,764 30,933
Customer deposits 48,747 3,623
Due to shareholders 292,500
Other accrued expenses and liabilities 30,711 10,507
Long-term debt - current portion 4,710,996
Total current liabilities 7,093,704 150,479
Long-Term Debt Less Current Portion 4,147,391
STOCKHOLDERS' EQUITY:
Preferred stock, $100 par value - authorized
500,000 shares, none issued
Common stock, $.10 par value - authorized
20,000,000 shares, 2,119,522 and 1,195,364 shares issued 211,952 119,536
Additional paid-in capital 3,906,540 1,577,706
Accumulated deficit (1,175,221) (13,030)
------------ -----------
Total stockholders' equity 2,943,271 1,684,212
------------ -----------
TOTAL $ 14,184,366 $ 1,834,691
============ ===========
</TABLE>
See accompanying notes to consolidated condensed financial statements.
3
<PAGE> 5
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended Nine months Ended
September 30, September 30,
2000 1999 2000 1999
----------- ---------- ----------- -----------
<S> <C> <C> <C> <C>
NET SALES $ 3,111,152 $ 196,000 $ 4,358,899 $ 844,976
COST OF GOODS SOLD 1,636,923 107,514 2,283,985 561,833
----------- --------- ----------- ---------
Gross profit 1,474,229 88,486 2,074,914 283,143
----------- --------- ----------- ---------
OPERATING EXPENSES:
Selling, general and administrative 1,417,145 188,012 2,323,483 544,136
Research and development 352,160 42,542 662,863 128,120
----------- --------- ----------- ---------
Total operating expenses 1,769,305 230,554 2,986,346 672,256
----------- --------- ----------- ---------
LOSS FROM OPERATIONS (295,076) (142,068) (911,432) (389,113)
----------- --------- ----------- ---------
OTHER INCOME (EXPENSE):
Interest and other income 234 7,795 17,181 28,022
Interest expense (205,268) (267,940)
----------- --------- ----------- ---------
Total other income (expense) (205,034) 7,795 (250,759) 28,022
----------- --------- ----------- ---------
LOSS BEFORE INCOME TAXES (500,110) (134,273) (1,162,191) (361,091)
INCOME TAX (BENEFIT) PROVISION
----------- --------- ----------- ---------
NET LOSS $ (500,110) $ (134,273) $(1,162,191) $(361,091)
=========== ========= =========== =========
LOSS PER SHARE
Basic $ (.24) $ (.16) $ (.72) $ (.44)
Diluted $ (.24) $ (.16) $ (.72) $ (.44)
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING -
Basic 2,090,312 824,442 1,620,852 821,738
Diluted 2,090,312 824,444 1,620,852 821,738
</TABLE>
See accompanying notes to consolidated condensed financial statements.
4
<PAGE> 6
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Nine months Ended
<TABLE>
<CAPTION>
September 30,
2000 1999
-----------------------------
<S> <C> <C>
OPERATING ACTIVITIES:
NET LOSS $(1,162,191) $(361,091)
ADJUSTMENTS TO RECONCILE NET (LOSS) INCOME
TO NET CASH PROVIDED BY (USED IN) OPERATING
ACTIVITIES:
Depreciation and amortization 439,963 23,391
Changes in assets and liabilities:
Accounts receivable (191,287) 27,525
Inventories (313,926) 264,250
Prepaid expenses and other assets (141,519) (1,942)
Accounts payable and accrued expenses 1,078,228 (45,812)
----------- ---------
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (290,732) (93,679)
----------- ---------
INVESTING ACTIVITIES:
Purchase of net assets of Orban, Inc. (1,963,783)
Purchase of securities (870,198)
Proceeds from sale or maturity of securities 383,905 585,698
Proceeds on sales of assets 5,394
Capital expenditures (37,051) (15,008)
----------- ---------
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (1,616,929) (294,114)
----------- ---------
FINANCING ACTIVITIES:
Proceeds from debt issuance 403,387
Shareholder advances 292,500
Principal payments on long-term debt (21,000)
Sale of treasury shares 571,875
Proceeds from sale of common stock 1,371,250
----------- ---------
NET CASH PROVIDED BY FINANCING ACTIVITIES 2,067,137 550,875
----------- ---------
NET INCREASE IN CASH AND CASH EQUIVALENTS 159,476 163,082
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 62,597 128,691
----------- ---------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 222,073 $ 291,773
=========== =========
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest $ 267,940
===========
</TABLE>
(continued)
5
<PAGE> 7
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
Nine months Ended
September 30,
2000 1999
-------------- -----------
<S> <C> <C>
SUPPLEMENTAL SCHEDULE OF NON CASH INVESTING
AND FINANCING ACTIVITIES:
Purchase of net assets of Orban, Inc.:
Fair value of assets acquired, including goodwill $ 12,885,626
Debt issued to seller (8,500,000)
Fair values of warrants issued to seller (1,050,000)
Debt issued to stockholder (205,000)
Liabilities assumed (868,628)
Costs paid in 1999 (298,215)
------------
Cash and costs paid $ 1,963,783
============
Unrealized appreciation of securities available-for -sale $ 9,074
============
</TABLE>
See accompanying notes to consolidated condensed financial statements.
6
<PAGE> 8
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
NINE MONTHS ENDED SEPTEMBER 30, 2000
(UNAUDITED)
<TABLE>
<CAPTION>
Common Stock Paid-In Accumulated Total
Shares Amount Capital Deficit
------ ------ ------- -------
<S> <C> <C> <C> <C> <C>
BALANCE,
January 1, 2000 597,682 $ 59,768 $ 1,637,474 $ (13,030) $ 1,684,212
Net loss (1,162,191) (1,162,191)
Issuance of
common shares 462,079 46,208 1,325,042 1,371,250
Issuance of warrants 1,050,000 1,050,000
Stock dividend 1,059,761 105,976 (105,976) -- --
--------- ---------- ----------- ----------- ----------
BALANCE,
September 30, 2000 2,119,522 $ 211,952 $ 3,906,540 $(1,175,221) $ 2,943,271
========= ========== =========== =========== =============
</TABLE>
7
<PAGE> 9
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Unaudited)
1. Basis of Presentation
The Consolidated Condensed Financial Statements included herein have been
prepared by Circuit Research Labs, Inc. ("CRL") include the accounts of CRL and
all of its subsidiaries, CRL Systems, Inc. ("CRL Systems"), and CRL
International, Inc. ("CRLI"), collectively, ("the Company"). The Consolidated
Condensed Balance Sheet as of December 31, 1999 and September 30, 2000 and the
Consolidated Condensed Statements of Operations for the three and nine months
ended September 30, 2000 and 1999 and the Consolidated Condensed Statements of
Cash Flows for the nine months ended September 30, 2000 and 1999 have been
prepared without audit.
Certain information and note disclosures normally included in financial
statements prepared in accordance with generally accepted accounting principles
have been condensed or omitted pursuant to such rules and regulations, although
the Company believes that the disclosures are adequate to make the information
presented not misleading. It is suggested that these Consolidated Condensed
Financial Statements be read in conjunction with the consolidated financial
statements and notes thereto included in the Company's Annual Report on Form
10-KSB for the year ended December 31, 1999.
In the opinion of management, the Consolidated Condensed Financial Statements
for the unaudited interim periods presented herein include all adjustments,
consisting only of normal recurring adjustments, necessary to present a fair
statement of the results of operations for such interim periods. Net operating
results for any interim period may not be comparable to the same interim period
in previous years, nor necessarily indicative of the results that may be
expected for the full year.
2. Stock Dividend
On July 7, 2000, the Board of Directors declared a 100 percent stock dividend of
one share of common stock for each share held, payable on August 15, 2000 to all
shareholders of record as of the close of business on July 31, 2000. Unless
otherwise noted, all references in the financial statements with regard to
number of shares of common stock and related dividends declared and income per
share amounts have been restated to reflect the stock dividend.
3. Earnings per Share
In calculating the loss per share for the three and nine months ended
September 30, 2000, the effects of 1,182,500 shares relating to options to
purchase common stock and 1,714,158 shares relating to warrants were not used
for computing diluted earnings per share because the results would be
antidilutive. In calculating the loss per share for the three and nine months
ended September 30, 1999, the effects of 1,000,000 total shares related to
options to purchase common shares were not used for computing the diluted loss
per share because the results would be antidilutive.
4. Business Combination
On May 31, 2000, CRL Systems acquired the net assets of Orban, Inc., a
wholly-owned subsidiary of Harman International Industries, Inc. Including the
$500,000 previously paid to Orban, as non-refundable deposits in 1999, the total
stated purchase price was $10.5 million, $2 million of which was paid in cash,
the balance a combination of short term and long-term seller financing. In order
to raise the cash necessary for the purchase, the Company sold approximately
$1,171,000 in
8
<PAGE> 10
common stock through a private placement, the Company's majority shareholder,
Charles Jayson Brentlinger, advanced $150,000 to the Company, and the Company's
Tempe, Arizona office building was mortgaged for $335,000. The seller financing
consists of a $3.5 million short term and a $5 million long-term note to Orban,
Inc. The Asset Sale Agreement between CRL Systems and Orban, Inc. ("the Asset
Sale Agreement") contains a provision to allow Orban to rescind the transaction
if, as of November 30, 2000, CRL Systems has not paid in full the $3.5 million
short term note. If Orban exercises its option to rescind the agreement, it is
to return $9,250,000 of the cash purchase price to CRL Systems, with the
difference due to Orban as liquidating damages.
In addition to the stated purchase price, CRL issued to Orban, Inc. warrants to
purchase 1,000,000 shares of its common stock, immediately exercisable for $2.25
per share. The warrants have a 3 year term, and can be exercised either in cash
or by reducing the unpaid principal amount of the $5 million long-term note, or
in any combination thereof. At June 30, 2000, in the absence of a independent
valuation, the warrants were valued using a Black-Scholes valuation model at
$4,125,000. When combined with the stated purchase price, this results in a
total purchase price of Orban's assets of $14,625,000. This purchase price was
used in the June 30, 2000 10-QSB, at that time the Company indicated that this
may be subject to revision depending upon results of an independent appraisal of
the warrant value. The Company obtained an independent valuation of the warrants
in November 2000 which valued the warrants at $1,050,000. When combined with the
cash purchase price, this results in a total purchase price of Orban's assets of
$11,550,000. The September 30, 2000 financial statements have been adjusted to
reflect this new valuation, including the reversal of approximately $36,000 in
amortization of goodwill previously reported.
As part of the acquisition, CRL Systems purchased the rights to the name "Orban"
and is currently operating under the dba "Orban".
The acquisition has been accounted for as a purchase and accordingly the net
assets and results of operations of Orban have been included in the consolidated
financial statements commencing May 31, 2000. The excess of the total
acquisition costs over the fair value of the assets acquired of approximately
$6.7 million is being amortized over 7 years. CRL is still gathering certain
information required to complete the allocation of the Orban asset purchase
price. Further adjustments may arise as a result of this analysis.
The following unaudited pro-forma summary combines the consolidated results of
operations of Circuit Research Labs and Orban as if the acquisition had occurred
on January 1 of that period after giving effect to certain adjustments including
amortization of the purchase price in excess of net assets acquired, corporate
general and administrative expenses, and income taxes. This pro-forma summary is
not necessarily indicative of the results of operations that would have occurred
if Circuit Research Labs and Orban had been combined during such periods.
Moreover, the pro-forma summary is not intended to be indicative of the results
of operations to be attained in the future.
<TABLE>
<CAPTION>
Nine Months Ended
September 30
2000 1999
----------- ------------
<S> <C> <C>
Net revenues $ 9,400,000 $ 10,500,000
Net loss $(1,348,000) $ (1,252,000)
Net loss per common share $ (.56) $ (.77)
</TABLE>
9
<PAGE> 11
5. Debt
Long term-debt at September 30, 2000 consisted of the following:
<TABLE>
<S> <C>
Orban, Inc. Tranche A Note $ 4,750,000
Orban, Inc. Tranche B Note 3,500,000
Note to shareholder 205,000
Mortgage note 335,000
Unsecured promissory note 68,387
-----------
Total long-term debt 8,858,387
Less current portion (4,710,996)
-----------
Total long-term debt, less current portion $ 4,147,391
===========
</TABLE>
There was no debt at September 30, 1999
In conjunction with the Asset Sale Agreement between Orban, Inc. and CRL
Systems, Inc., CRL Systems and Orban entered into a Credit Agreement to
establish the terms and conditions of the $8,500,0000 loan from Orban to CRL
Systems. The loan is evidenced by two promissory notes, the Senior Subordinated
Tranche A Note (the "Tranche A Note") and the Senior Subordinated Tranche B Note
(the "Tranche B Note"). The Tranche A Note, in the amount of $5,000,000, bears
interest at 8 percent per annum and requires quarterly principal payments
beginning March 31, 2001, with a balloon payment of $3,000,000 due on March 31,
2003. Based on current interest rates this includes a discount of $250,000. The
Tranche B Note, in the amount of $3,500,000, bears interest at 8 percent per
annum for the period from June 1, 2000 to July 31, 2000 and 10 percent per annum
from August 1, 2000 up to its September 30, 2000 maturity date. The September
30, 2000 maturity date on the Tranche B note has been extended to November 30,
2000. A fee for $150,000 was paid to Harman for this extension. The notes are
secured by, among other things, all receivables, inventory and equipment,
investment property, including CRL's capital stock in CRL Systems, and
intellectual property of CRL and CRL Systems, as defined in the "Guarantee and
Collateral Agreement". The Company has received a preliminary proposal to obtain
line of $3,500,000, a portion of which will be used to pay the Tranche B note.
In consideration for arranging the purchase financing of Orban, the Company
incurred fees of $97,500 to a shareholder for financing, the total of which is
included Due to Shareholders at September 30, 2000. Such deferred financing fees
and will be amortized over three years.
The Company issued $205,000 in long-term debt to a shareholder in consideration
for his role in the acquisition of the assets of Orban, Inc. The note bears
interest at 7.5 per cent per annum, with principal and interest due monthly
beginning August 1, 2000 for four years. The original amount of the note has
been included in the total acquisition costs of the Orban assets. The August 1,
2000 and September 1, 2000 payments were made October 17, 2000 by agreement of
the shareholder.
At September 30, 2000, included in Due to Shareholders is $195,000 the Company
received in non-interest bearing cash advances from Mr. Brentlinger. There is no
stated term on the advances.
On May 30, 2000, the Company mortgaged its office building and manufacturing
facility in Tempe, Arizona for $335,000. The mortgage note bears interest at
15.25 percent per annum, payable monthly, and the full principal balance was to
be paid on November 30, 2000. This maturity date
10
<PAGE> 12
has been extended to December 31, 2000. The Company has signed a letter of
commitment for a new mortgage with a term of five years to retire the current
mortgage.
On June 12, 2000 the Company entered into a promissory note for $68,387 from an
employee. The note bears interest at 12 percent per annum. All principal and
interest was due September 12, 2000, however the maturity date has been extended
to January 2, 2001. The note is unsecured.
The following represents the principal maturities of debt over the next five
years:
<TABLE>
<S> <C>
September 30, 2001 4,710,996
September 30, 2002 1,049,202
September 30, 2003 3,040,975
September 30, 2004 57,214
</TABLE>
6. Stockholders' Equity
Common Stock and Warrants Subscription Agreement: During the second and third
quarters of 2000, the Company sold in a private placement, for $1.50 per share,
714,158 units of common stock and warrants under a subscription agreement (the
"Subscription Agreement") with accredited investors. Under the agreement, each
unit consists of one share the Company's common stock and one warrant (the
"Class A Warrants") to purchase at an exercise price of $1.75 per share one
share of the Company's common stock and one Class B Warrant (as defined). The
Class A Warrant may be exercised for a sixty day period following the
registration of the shares issuable upon exercise of the Class A Warrants. The
holder of a Class A Warrant shall not have the right to obtain a Class B Warrant
if the Class A Warrant is not timely exercised.
Each Class B Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.00 per share one share of the Company's common stock and
one Class C Warrant. The holder of a Class B Warrant shall not have the right to
obtain a Class C Warrant if the Class B Warrant is not timely exercised, as
defined in the subscription agreement.
Each Class C Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.25 per share one share of the Company's common stock and
one Class D Warrant. The holder of a Class C Warrant shall not have the right to
obtain a Class D Warrant if the Class C Warrant is not timely exercised, as
defined in the subscription agreement.
Each Class D Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.50 per share one share of the Company's common stock.
If all of the warrants were exercised at the stated value per share the total
exercised value would be $6,070,342.
Stock Options Exercised: In the second quarter of 2000, Mr. Brentlinger
purchased 160,000 shares of the Company's common stock for $1.25 per share under
the 1999 stock purchase agreement between himself and the Company. Under such
agreement, Mr. Brentlinger was obligated to purchase 342,500 shares on or before
September 30, 2000 for $1.25 per share. On October 20, 2000, the purchase date
was extended to December 31, 2000. As of September 30, 2000 he remains obligated
to purchase 182,500 shares on or before December 31, 2000 for a total price of
$228,125
11
<PAGE> 13
ITEM. 2
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Introduction
On May 31, 2000, CRL Systems acquired the net assets of Orban, Inc., a
wholly-owned subsidiary of Harman International Industries, Inc. Including the
$500,000 non-refundable deposit previously paid to Orban, the total stated
purchase price was $10.5 million. In addition to the cash purchase price, CRL
issued to Orban, Inc. warrants to purchase 1,000,000 shares of its common stock,
immediately exercisable for $2.25 per share. Accordingly, the net assets and
results of operations of CRL Systems Inc d.b.a. Orban ("Orban") have been
included in these financial statements commencing May 31, 2000.
On July 7, 2000, the Board of Directors declared a 100 percent stock dividend of
one share of common stock for each share held, payable on August 15, 2000 to all
shareholders of record as of the close of business on July 31, 2000. Unless
otherwise noted, all references with regard to number of shares of common stock
and related dividends declared and income per share amounts have been restated
to reflect the stock dividend.
Results of Operations
Net Revenues. Total net revenues during the three and nine months ended
September 30, 2000, were $3.1 million and $4.4 million, respectively, compared
to $196,000 and $845,000 during the comparable periods in 1999, respectively,
reflecting an increase of 1487% and 416%, respectively. The increase in the net
revenues was primarily attributable to Orban revenues to the consolidated group,
offset by a decrease in CRL revenues, as CRL continues to experience slower
demand across its product lines, in both domestic and international markets.
Gross Profit. The increased revenue levels generated gross profit of $1.5
million and $2.1 million for the three and nine months ended September 30, 2000,
which was an increase of 1566% and 633% over the comparable periods in 1999,
respectively. Gross profit as a percentage of net revenues increased from 45% to
47% for the three months ended September 30, 2000 as compared to the three
months ended September 30, 1999. Gross profit as a percentage of net revenues
increased from 34% to 48% for the nine months ended September 30, 2000. The
gross profit percentage improved as a result of the acquisition of Orban and the
Company's decision not to dissolve in May 1999 and thereby returning to selling
it's inventory at normal margins subsequent to such time.
Selling, General and Administrative. Total selling, general, and administrative
expenses ("SG&A") increased 654% and 327% for the three and nine months ended
September 30, 2000 as compared to the same periods during 1999, respectively. As
a percentage of revenues, SG&A went from 96% to 45% for the three months ended
September 30, 1999 versus 2000, respectively, and from 64% to 53% for the nine
months ended September 30, 1999 versus 2000, respectively. The increased SG&A
dollars are due in part to the variable component of SG&A (commissions and other
12
<PAGE> 14
domestic and international sales and marketing expenses) associated with the
increased revenues resulting from the acquisition of Orban. The fixed component
of SG&A has also increased due to additional personnel in sales, marketing and
administration, amortization of goodwill, and costs related to Orban. As a
result SG&A is expected to be higher throughout 2000 compared to 1999.
Amortization of goodwill for the 9 months ended September 30, 2000 was $282,000.
Research and Development. Research and development expenses increased 728% and
417% for the three and nine months ended September 30, 2000 as compared to the
same periods during 1999. The increase is the result of an increase in the
number of engineering staff at CRL and ongoing research and development
activities at Orban.
Other Income (Expense). Other income (expense) was ($205,000) and ($251,000) for
the three and nine months ended September 30, 2000 compared to $8,000 and
$28,000 for the same periods in 1999. Other income in 1999 consisted of interest
on the Company's marketable securities and the cash surrender value of a life
insurance policy. In 2000, the marketable securities had been sold, leaving no
source for interest income after the first quarter and the Company entered into
various forms of debt to finance the purchase of Orban's assets, resulting in
interest expense of $205,000 and $268,000 for the three and nine months ended
September 30, 2000.
The Company has received a preliminary proposal to obtain line of $3,500,000, a
portion of which will be used to pay the Tranche B note. CRL plans to attempt to
raise additional capital during fiscal year 2000 with a private equity placement
of an undetermined number of shares of CRL's common stock. CRL intends to apply
any such additional capital to debt repayment with any excess funds to be used
for product development, and working capital requirements above those funded
from operations. The Company has not yet entered into any agreements for this
planned private equity funding. Material adverse effects will occur if funding
cannot be obtained. See "Liquidity and Capital Resources."
Liquidity and Capital Resources
As discussed above, on May 31, 2000, CRL Systems acquired the net assets of
Orban, Inc., a wholly-owned subsidiary of Harman International Industries, Inc.
Including the $500,000 previously paid to Orban, the total stated purchase price
was $10.5 million, $2 million of which was paid in cash, the balance a
combination of short term and long-term seller financing. In order to raise the
cash necessary for the purchase, the Company sold approximately $1,171,000 in
common stock through private placements, the Company's majority shareholder,
Charles Jayson Brentlinger, advanced $150,000 to the Company, and the Company's
Tempe, Arizona office building was mortgaged for $335,000. The seller financing
consists of a $3.5 million short term and a $5 million long-term note to Orban,
Inc. The Asset Sale Agreement between CRL Systems and Orban, Inc. ("the Asset
Sale Agreement") contains a provision to allow Orban to rescind the transaction
if, as of November 30, 2000, CRL Systems has not paid in full the $3.5 million
short term note. If Orban exercises its option to rescind the agreement, it is
to return $9,250,000 of the stated purchase price to CRL Systems, with the
difference due to Orban as liquidating damages.
In addition to the stated purchase price, CRL issued to Orban, Inc. warrants to
purchase 1,000,000 shares of its common stock, immediately exercisable for $2.25
per share. The warrants have a 3 year term, and can be exercised either in cash
or by reducing the unpaid principal amount of the $5 million long-term note, or
in any combination thereof. At June 30, 2000, in the absence of a independent
valuation, the warrants were valued using a Black-Scholes valuation model at
13
<PAGE> 15
$4,125,000. When combined with the stated purchase price, this results in a
total purchase price of Orban's assets of $14,625,000. This purchase price was
used in the June 30, 2000 10-QSB, at that time the Company indicated that this
may be subject to revision depending upon results of an independent appraisal of
the warrant value. The Company obtained an independent valuation of the warrants
in November 2000 which valued the warrants at $1,050,000. When combined with the
cash purchase price, this results in a total purchase price of Orban's assets of
$11,550,000. The September 30, 2000 financial statements have been adjusted to
reflect this new valuation.
The Company issued $205,000 in long-term debt to a shareholder in consideration
for his role in the acquisition of the assets of Orban, Inc. The note bears
interest at 7.5 per cent per annum, with principal and interest due monthly
beginning August 1, 2000 for four years. The original amount of the note has
been included in the total acquisition costs of the Orban assets. The August 1,
2000 and September 1, 2000 payments were made October 17, 2000 by agreement of
the shareholder.
In conjunction with the Asset Sale Agreement between Orban, Inc. and CRL
Systems, Inc., CRL Systems and Orban entered into a Credit Agreement to
establish the terms and conditions of the $8,500,0000 loan from Orban to CRL
Systems. The loan is evidenced by two promissory notes, the Senior Subordinated
Tranche A Note (the "Tranche A Note") and the Senior Subordinated Tranche B Note
(the "Tranche B Note"). The Tranche A Note, in the amount of $5,000,000, bears
interest at 8 percent per annum and requires quarterly principal payments
beginning March 31, 2001, with a balloon payment of $3,000,000 due on March 31,
2003. Based on current interest rates this includes a discount of $250,000. The
Tranche B Note, in the amount of $3,500,000, bears interest at 8 percent per
annum for the period from June 1, 2000 to July 31, 2000 and 10 percent per annum
from August 1, 2000 up to its September 30, 2000 maturity date. The September
30, 2000 maturity date on the Tranche B note has been extended to November 30,
2000. A fee for $150,000 was paid to Harman for this extension. The notes are
secured by, among other things, all receivables, inventory and equipment,
investment property, including CRL's capital stock in CRL Systems, and
intellectual property of CRL and CRL Systems, as defined in the "Guarantee and
Collateral Agreement". The Company has received a preliminary proposal to obtain
line of $3,500,000, a portion of which will be used to pay the Tranche B note.
As of June 30, 2000, there was outstanding $195,000 in non-interest bearing cash
advances the Company received from Mr. Brentlinger. There is no stated term on
the advances.
On May 30, 2000, the Company mortgaged its office building and manufacturing
facility in Tempe, Arizona for $335,000. The mortgage note bears interest at
15.25 percent per annum, payable monthly, and the full principal balance due in
November 2000. The November 30, 2000 maturity date on this mortgage has been
extended to December 31, 2000. The Company has signed a letter of commitment for
a new mortgage with a term of five years to retire the current mortgage.
On June 12, 2000 the Company entered into a promissory note for $68,387 from an
employee. The note bears interest at 12 percent per annum. All principal and
interest is due September 12, 2000. The note is unsecured. The September 12,
2000 maturity date on the note has been extended to January 2, 2001.
During the second and third quarters of 2000, the Company sold in a private
placement, for $1.50 per share, 714,158 units of common stock and warrants under
a subscription agreement (the "Subscription Agreement") with accredited
investors. Under the agreement, each unit consists of one share the Company's
common stock and one warrant (the "Class A Warrants") to purchase at an exercise
price of $1.75 per share one share of the Company's common stock and one Class B
14
<PAGE> 16
Warrant (as defined). The Class A Warrant may be exercised for a sixty day
period following the registration of the shares issuable upon exercise of the
Class A Warrants. The holder of a Class A Warrant shall not have the right to
obtain a Class B Warrant if the Class A Warrant is not timely exercised. Each
Class B Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.00 per share one share of Company's common stock and one
Class C Warrant. The holder of a Class B Warrant shall not have the right to
obtain a Class C Warrant if the Class B Warrant is not timely exercised, as
defined in the subscription agreement. Each Class C Warrant, if and when issued,
will be a warrant to purchase at an exercise price of $2.25 per share one share
of Company's common stock and one Class D Warrant. The holder of a Class C
Warrant shall not have the right to obtain a Class D Warrant if the Class C
Warrant is not timely exercised, as defined in the subscription agreement. Each
Class D Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.50 per share one share of Company's common stock. If all of
the warrants were exercised at the stated value per share the total exercised
value would be $6,070,342.
During the second quarter of 2000, Mr. Brentlinger purchased 160,000 shares of
the Company's common stock for $1.25 per share under the 1999 stock purchase
agreement between himself and the Company. Under such agreement, Mr. Brentlinger
was obligated to purchase 342,500 shares on or before September 30, 2000 for
$1.25 per share. At June 30, 2000, he remains obligated to purchase 182,500
shares on or before September 30, 2000. On October 20, 2000, the purchase date
was extended to December 31, 2000. As of September 30, 2000 he remains obligated
to purchase 182,500 shares on or before December 31, 2000 for a total price of
$228,125
At September 30, 2000, the Company had cash of $222,000. The Company had a
negative net working capital of approximately $1,313,000 September 30, 2000
compared to positive working capital of $945,000 at December 31, 1999. The
Company will attempt to address the deficit in working capital through seeking a
combination of accounts receivable and asset based financing.
The Company will need additional capital during the next three months, primarily
to meet its debt obligations described above. The Company has received a
preliminary proposal to obtain a $3,500,000 line of credit. The Company will
attempt to seek additional such capital through a private equity placement of
its common stock, through asset-based lending, or a combination thereof. There
is no assurance that the Company will be able to attract additional capital or
that the funds, if acquired, will be sufficient to meet its debt obligations or
operating capital requirements. Material adverse effects will occur if funding
cannot be obtained.
15
<PAGE> 17
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
PART II. OTHER INFORMATION
Item 2. Changes in use of securities and use of proceeds
During the second and third quarters of 2000, the Company sold in a private
placement, for $1.50 per share, 714,158 units of common stock and warrants under
a subscription agreement (the "Subscription Agreement") with accredited
investors. Under the agreement, each unit consists of one share the Company's
common stock and one warrant (the "Class A Warrants") to purchase at an exercise
price of $1.75 per share one share of the Company's common stock and one Class B
Warrant (as defined). The Class A Warrant may be exercised for a sixty day
period following the registration of the shares issuable upon exercise of the
Class A Warrants. The holder of a Class A Warrant shall not have the right to
obtain a Class B Warrant if the Class A Warrant is not timely exercised. Each
Class B Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.00 per share one share of Company's common stock and one
Class C Warrant. The holder of a Class B Warrant shall not have the right to
obtain a Class C Warrant if the Class B Warrant is not timely exercised, as
defined in the subscription agreement. Each Class C Warrant, if and when issued,
will be a warrant to purchase at an exercise price of $2.25 per share one share
of Company's common stock and one Class D Warrant. The holder of a Class C
Warrant shall not have the right to obtain a Class D Warrant if the Class C
Warrant is not timely exercised, as defined in the subscription agreement. Each
Class D Warrant, if and when issued, will be a warrant to purchase at an
exercise price of $2.50 per share one share of Company's common stock.
Item 5. Other Information
The Company's common shares are no longer listed on the NASDAQ Small Cap market,
but as of April 1, 1998, the shares have been listed on the OTC Bulletin Board.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits included herein: none
(b) Reports on Form 8-K - 8-K filed on August 14, 2000
16
<PAGE> 18
CIRCUIT RESEARCH LABS, INC. AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Registrant
CIRCUIT RESEARCH LABS, INC.
DATE: November 20, 2000
BY /s/Charles Jayson Brentlinger
------------------------------
Charles Jayson Brentlinger
President (Authorized Officer for
signature)
17
<PAGE> 19
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit
Number Description of Exhibit
-------- -------------------------
<S> <C>
27 Financial Data Schedule
</TABLE>
